Q4 2025 Holdings
Filed 2026-02-12 | 42 holdings | $284.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Delcath Systems, Inc.(DCTH) | COM NEW | 24661P807 | $33.0M | 3,300,389 | 11.6% |
| Savara Inc(SVRA) | COM | 805111101 | $20.5M | 3,403,721 | 7.2% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $20.1M | 2,613,508 | 7.1% |
| Xeris Biopharma Holdgs Inc(XERS) | COM | 98422E103 | $16.6M | 2,111,700 | 5.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $14.0M | 450,000 | 4.9% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $13.8M | 749,054 | 4.9% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $13.8M | 1,788,475 | 4.9% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $13.7M | 1,410,497 | 4.8% |
| Astria Therapeutics Inc(ATYR) | COM | 002120202 | $13.6M | 1,039,080 | 4.8% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $13.6M | 1,657,540 | 4.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $12.6M | 690,000 | 4.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $12.5M | 300,000 | 4.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $12.4M | 195,045 | 4.4% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $10.4M | 2,605,920 | 3.7% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $10.0M | 750,000 | 3.5% |
| Profound Medical Corp(PROF) | COM NEW | 74319B502 | $8.4M | 1,068,955 | 3.0% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $7.0M | 3,905,743 | 2.4% |
| Ocular Therapeutix, Inc(OCUL) | COM | 67576A100 | $4.9M | 400,000 | 1.7% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $4.3M | 215,871 | 1.5% |
| Talphera Inc(TLPH) | COM NEW | 00444T209 | $4.1M | 3,579,273 | 1.4% |
| Myomo Inc(MYO) | COM NEW | 62857J201 | $3.5M | 3,839,772 | 1.2% |
| Invesco QQQ TRPut | PUT | 46090E953 | $3.0M | 450,000 | 1.1% |
| Polypid LTD(PYPD) | COM | M8001Q126 | $3.0M | 696,556 | 1.1% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $2.1M | 730,488 | 0.7% |
| Spdr S&P 500 ETF TRPut | PUT | 78462F953 | $1.9M | 510,000 | 0.7% |
| Anavex Life Sciences CorpPut | PUT | 032797950 | $1.9M | 1,168,600 | 0.7% |
| Regentis Biomaterials LTD | ORDINARY SHARES | M8211G108 | $1.7M | 251,510 | 0.6% |
| Spdr Series TrustPut | PUT | 78464A950 | $1.3M | 1,937,600 | 0.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $1.3M | 100,000 | 0.4% |
| Ishares TRPut | PUT | 464287955 | $1.1M | 200,000 | 0.4% |
| Neuraxis Inc(NRXS) | COM | 64134X201 | $1.0M | 286,138 | 0.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.0M | 100,000 | 0.4% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $848.6K | 385,731 | 0.3% |
| Biofrontera Inc(BFRI) | COM NEW | 09077D209 | $650.2K | 1,140,764 | 0.2% |
| Arrivent Biopharma IncCall | CALL | 04272N902 | $539.5K | 107,900 | 0.2% |
| Verastem IncCall | CALL | 92337C903 | $159.8K | 268,600 | 0.1% |
| Uniqure NVCall | CALL | N90064901 | $95.0K | 100,000 | 0.0% |
| Replimune Group IncCall | CALL | 76029N906 | $11.5K | 230,900 | 0.0% |
| Viking Therapeutics IncCall | CALL | 92686J906 | $2.0K | 100,000 | 0.0% |
| Vistagen Therapeutics IncCall | CALL | 92840H900 | $0 | 493,400 | 0.0% |
| Replimune Group IncPut | PUT | 76029N956 | $0 | 264,700 | 0.0% |
| Rezolute IncCall | CALL | 76200L909 | $0 | 263,100 | 0.0% |